Agilent Technologies (A)

$126.72 -0.47 (-0.37%)
Market Cap 35.62B
Revenue (ttm) 6.51B
Net Income (ttm) 1.29B
EPS (ttm) N/A
PE Ratio 22.61
Forward PE 22.11
Profit Margin 19.80%
Debt to Equity Ratio 0.53
Volume 1,921,679
Avg Vol 1,695,356
Day's Range N/A - N/A
Shares Out 283.50M
Stochastic %K 52%
Beta 1.24
Analysts Sell
Price Target $139.21

Company Profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems;...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 800 227 9770
Fax: 866 497 1134
Address:
5301 Stevens Creek Boulevard, Santa Clara, United States
StockAutoPro
StockAutoPro Sep. 17 at 4:11 PM
$A: Buy target $126.79 Sell target $135.23 Pharmaceutical company's promising drug pipeline could drive significant future growth.
0 · Reply
Broview
Broview Sep. 17 at 12:42 AM
$A trending up?
0 · Reply
Estimize
Estimize Sep. 16 at 2:48 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
JackDarwin
JackDarwin Sep. 16 at 11:44 AM
$A Bullish Harami Candlestick Pattern.
0 · Reply
JarvisFlow
JarvisFlow Sep. 15 at 1:00 PM
Wells Fargo has updated their rating for Agilent Technologies ( $A ) to Overweight with a price target of 150.
0 · Reply
BITTYWASTENCENTS
BITTYWASTENCENTS Sep. 13 at 9:16 PM
$BTC.X Why did Trump world liberty bought so much $EOS.X just before it rebranded to VAULTA $A? Maybe because Vaulta bridges web3 banking to financial institutions 🤣🤣🤣 and may find its newfound purpose as an Ethureum on steriods
1 · Reply
Broview
Broview Sep. 13 at 7:16 AM
$A trending up?
0 · Reply
TheGodofgreat
TheGodofgreat Sep. 12 at 5:05 PM
$A, $AIG, $ALGN $AFL
0 · Reply
Estimize
Estimize Sep. 9 at 2:51 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
StockAutoPro
StockAutoPro Sep. 4 at 2:14 PM
$A: Buy target $123.08 Sell target $131.33 Strong financials and rising demand indicate potential growth in this leading healthcare company.
0 · Reply
Latest News on A
Agilent Announces Cash Dividend of 24.8 Cents per Share

Sep 17, 2025, 4:05 PM EDT - 2 hours ago

Agilent Announces Cash Dividend of 24.8 Cents per Share

Agilent to Participate in 2025 Bank of America Global Healthcare Conference

Sep 11, 2025, 4:15 PM EDT - 6 days ago

Agilent to Participate in 2025 Bank of America Global Healthcare Conference

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

Sep 9, 2025, 8:00 AM EDT - 8 days ago

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science

Sep 8, 2025, 4:30 PM EDT - 9 days ago

Agilent (A) CEO on PFAS Testing Growth & Creating Advanced Instruments for Science

Agilent Technologies, Inc. (A) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 3, 2025, 5:28 PM EDT - 14 days ago

Agilent Technologies, Inc. (A) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Sep 3, 2025, 8:00 AM EDT - 14 days ago

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

Sep 2, 2025, 8:00 AM EDT - 15 days ago

Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

Agilent: Growth Across All Segments, But Investors Will Need To Be Patient

Aug 28, 2025, 8:34 AM EDT - 20 days ago

Agilent: Growth Across All Segments, But Investors Will Need To Be Patient

Agilent Technologies, Inc. (A) Q3 2025 Earnings Call Transcript

Aug 27, 2025, 8:00 PM EDT - 20 days ago

Agilent Technologies, Inc. (A) Q3 2025 Earnings Call Transcript

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

Aug 27, 2025, 4:05 PM EDT - 21 days ago

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

Life sciences firm Agilent raises annual revenue outlook

Aug 27, 2025, 4:03 PM EDT - 21 days ago

Life sciences firm Agilent raises annual revenue outlook

Agilent to Participate in 2025 Wells Fargo Healthcare Conference

Aug 21, 2025, 4:15 PM EDT - 27 days ago

Agilent to Participate in 2025 Wells Fargo Healthcare Conference

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

Aug 20, 2025, 8:00 AM EDT - 4 weeks ago

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

Aug 13, 2025, 8:00 AM EDT - 5 weeks ago

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs

Aug 4, 2025, 8:00 AM EDT - 6 weeks ago

Agilent Expands the Dako Omnis Family with Three New Models to Meet Evolving Pathology Lab Needs

Monthly Pay Dividends, From 83 Equities, 80 Funds, And 28 Ideal 'Safer' Dogs For August

Aug 1, 2025, 8:01 AM EDT - 6 weeks ago

Monthly Pay Dividends, From 83 Equities, 80 Funds, And 28 Ideal 'Safer' Dogs For August

AGNC APLE

Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says

Jul 29, 2025, 9:10 AM EDT - 7 weeks ago

Agilent Tech looks to double investments in India, eyes high-teen growth, CEO says

Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27

Jul 17, 2025, 4:30 PM EDT - 2 months ago

Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27

Agilent Announces CFO Transition

Jul 15, 2025, 8:30 AM EDT - 2 months ago

Agilent Announces CFO Transition

Agilent to Showcase New Products and Innovations at HPLC 2025

Jun 12, 2025, 8:00 AM EDT - 3 months ago

Agilent to Showcase New Products and Innovations at HPLC 2025

Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)

Jun 4, 2025, 12:17 PM EDT - 3 months ago

Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)

Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript

May 28, 2025, 6:38 PM EDT - 3 months ago

Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript

Life sciences firm Agilent beats quarterly estimates on instrument demand

May 28, 2025, 4:58 PM EDT - 4 months ago

Life sciences firm Agilent beats quarterly estimates on instrument demand

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results

May 28, 2025, 4:05 PM EDT - 4 months ago

Agilent Reports Second-Quarter Fiscal Year 2025 Financial Results

Agilent Names August Specht as Chief Technology Officer

May 28, 2025, 8:30 AM EDT - 4 months ago

Agilent Names August Specht as Chief Technology Officer

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

May 27, 2025, 8:01 AM EDT - 4 months ago

Agilent Announces the Enhanced 8850 Gas Chromatograph: Compact, Powerful, and Now Mass Spec-Connected for Superior Analytical Performance

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

May 27, 2025, 8:00 AM EDT - 4 months ago

Agilent Unveils the Next Generation in LC-Mass Detection: The InfinityLab Pro iQ Series

Agilent Announces Cash Dividend of 24.8 Cents per Share

May 21, 2025, 4:05 PM EDT - 4 months ago

Agilent Announces Cash Dividend of 24.8 Cents per Share

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors

May 21, 2025, 8:30 AM EDT - 4 months ago

Pascal Soriot and Judy Gawlik Brown Named to Agilent Board of Directors

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

May 20, 2025, 8:00 AM EDT - 4 months ago

Agilent Announces My Green Lab Ecolabel 2.0 for the New Infinity III LC Series

Agilent to Participate in Jefferies Global Healthcare Conference

May 15, 2025, 4:14 PM EDT - 4 months ago

Agilent to Participate in Jefferies Global Healthcare Conference

Scale Has Its Advantages: 3 A-Rated REIT Monopolies

May 10, 2025, 7:00 AM EDT - 4 months ago

Scale Has Its Advantages: 3 A-Rated REIT Monopolies

AMT DLR EXR MAA O PLD PSA

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research

May 1, 2025, 8:00 AM EDT - 4 months ago

Agilent Unveils Transformative Seahorse XF Flex Analyzer: Revolutionizing 3D Tissue and Organoid Research

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

Apr 24, 2025, 9:52 AM EDT - 5 months ago

City Office REIT (RED PFD SER A): A High Yield, Deep Value Opportunity Worth Latching Onto

CIO

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission

Apr 24, 2025, 8:30 AM EDT - 5 months ago

Smackover Lithium's South West Arkansas Project Receives Unanimous Vote of Approval to Establish the Phase I Brine Production Unit from the Arkansas Oil and Gas Commission

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

Apr 24, 2025, 8:00 AM EDT - 5 months ago

Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Apr 17, 2025, 8:00 AM EDT - 5 months ago

Agilent Receives European IVDR Certification for Companion Diagnostic Assay in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

Apr 3, 2025, 7:00 AM EDT - 5 months ago

Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today

CSX JBHT NKE OMC PPG TGT

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

Mar 24, 2025, 8:00 AM EDT - 6 months ago

Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Mar 20, 2025, 1:37 PM EDT - 6 months ago

CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Mar 20, 2025, 8:00 AM EDT - 6 months ago

Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

Mar 19, 2025, 8:00 AM EDT - 6 months ago

Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Mar 10, 2025, 8:19 AM EDT - 6 months ago

Agilent PD-L1 IHC 28-8 pharmDx Receives EU IVDR Certification as a Companion Diagnostic Test for Non-small Cell Lung Cancer and Melanoma Indications

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 4, 2025, 3:55 PM EST - 7 months ago

Agilent Technologies, Inc. (A) TD Cowen 45th Annual Healthcare Conference (Transcript)

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

Mar 1, 2025, 2:04 AM EST - 7 months ago

Agilent Technologies: Recent Price Weakness Makes This Stock A Buy

Agilent to Participate in TD Cowen Health Care Conference

Feb 27, 2025, 9:29 PM EST - 7 months ago

Agilent to Participate in TD Cowen Health Care Conference

Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript

Feb 26, 2025, 9:28 PM EST - 7 months ago

Agilent Technologies, Inc. (A) Q1 2025 Earnings Call Transcript

Agilent lowers annual revenue forecast on soft demand for medical equipment

Feb 26, 2025, 4:46 PM EST - 7 months ago

Agilent lowers annual revenue forecast on soft demand for medical equipment

Agilent Reports First-Quarter Fiscal Year 2025 Financial Results

Feb 26, 2025, 4:04 PM EST - 7 months ago

Agilent Reports First-Quarter Fiscal Year 2025 Financial Results

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26

Jan 24, 2025, 5:59 PM EST - 8 months ago

Agilent to Announce First-Quarter Fiscal Year 2025 Financial Results on Feb. 26

StockAutoPro
StockAutoPro Sep. 17 at 4:11 PM
$A: Buy target $126.79 Sell target $135.23 Pharmaceutical company's promising drug pipeline could drive significant future growth.
0 · Reply
Broview
Broview Sep. 17 at 12:42 AM
$A trending up?
0 · Reply
Estimize
Estimize Sep. 16 at 2:48 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
JackDarwin
JackDarwin Sep. 16 at 11:44 AM
$A Bullish Harami Candlestick Pattern.
0 · Reply
JarvisFlow
JarvisFlow Sep. 15 at 1:00 PM
Wells Fargo has updated their rating for Agilent Technologies ( $A ) to Overweight with a price target of 150.
0 · Reply
BITTYWASTENCENTS
BITTYWASTENCENTS Sep. 13 at 9:16 PM
$BTC.X Why did Trump world liberty bought so much $EOS.X just before it rebranded to VAULTA $A? Maybe because Vaulta bridges web3 banking to financial institutions 🤣🤣🤣 and may find its newfound purpose as an Ethureum on steriods
1 · Reply
Broview
Broview Sep. 13 at 7:16 AM
$A trending up?
0 · Reply
TheGodofgreat
TheGodofgreat Sep. 12 at 5:05 PM
$A, $AIG, $ALGN $AFL
0 · Reply
Estimize
Estimize Sep. 9 at 2:51 PM
Wall St is expecting 1.58 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
StockAutoPro
StockAutoPro Sep. 4 at 2:14 PM
$A: Buy target $123.08 Sell target $131.33 Strong financials and rising demand indicate potential growth in this leading healthcare company.
0 · Reply
StockAutoPro
StockAutoPro Sep. 2 at 8:18 PM
$A: Buy target $123.21 Sell target $131.47 Strong earnings report could indicate growth potential in leading aerospace company.
0 · Reply
Estimize
Estimize Sep. 2 at 8:00 PM
Wall St is expecting 1.59 EPS for $A Q4 [Reporting 12/01 AMC] http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=
0 · Reply
WinstonChurshill
WinstonChurshill Sep. 2 at 6:46 AM
$MNRS $A big old Frank Thomas $35 coming upppp!
0 · Reply
StockAutoPro
StockAutoPro Aug. 31 at 3:59 AM
$A: Buy target $123.66 Sell target $131.94 Increased demand for renewable energy could boost this solar company's growth.
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 6:03 PM
$A 🚀 Strong Q3 across the board Agilent beat on both earnings and revenue, delivered double-digit sales growth, and guided higher — all fueling the stock move up. Full earnings breakdown here 👉 https://www.zacks.com/stock/news/2744477/agilent-q3-earnings-beat-estimates-revenues-up-yy-shares-rise?cid=sm-stocktwits-2-2744477-teaser-10123&ADID=SYND_STOCKTWITS_TWEET_2_2744477_TEASER_10123
0 · Reply
ZacksResearch
ZacksResearch Aug. 28 at 5:03 PM
$A beats Q3 expectations, but is it enough to reverse its slide? 📉 Agilent Technologies reported Q3 EPS of $1.37, beating the Zacks Consensus Estimate by 0.74%, with revenues surpassing expectations by 4.6%. Yet, shares are down 8.4% compared to a 2.5% dip in the Zacks Medical sector. Discover if $A can regain momentum here 👉 https://www.zacks.com/stock/news/2744477/agilent-q3-earnings-beat-estimates-revenues-up-yy-shares-rise?cid=sm-stocktwits-2-2744477-body-10101&ADID=SYND_STOCKTWITS_TWEET_2_2744477_BODY_10101
0 · Reply
JarvisFlow
JarvisFlow Aug. 28 at 3:25 PM
Baird updates rating for Agilent Technologies ( $A ) to Outperform, target set at 141 → 142.
0 · Reply
JarvisFlow
JarvisFlow Aug. 28 at 2:47 PM
Wells Fargo updates rating for Agilent Technologies ( $A ) to Overweight, target set at 135 → 140.
0 · Reply
JarvisFlow
JarvisFlow Aug. 28 at 1:00 PM
Evercore ISI Group has adjusted their stance on Agilent Technologies ( $A ), setting the rating to In-Line with a target price of 130 → 128.
0 · Reply
Estimize
Estimize Aug. 27 at 11:00 PM
$A reported 1.37 EPS and 1,738 revenue for Q3. http://www.estimize.com/intro/a?chart=historical&metric_name=eps&utm_content=A&utm_medium=ac
0 · Reply
CatCapital_ai
CatCapital_ai Aug. 27 at 8:07 PM
$A Earnings - Q3/2025 Revenue: $1.74B ✅ vs. $1.67B est. EPS: $1.37 ✅ vs. $1.37 est. Agilent beats expectations with 10.1% revenue growth in Q3, driven by all business units and regions. The company raises its full-year outlook, with continued momentum across life sciences and diagnostics. Strong operational execution fuels confidence in Q4 growth, amid a dynamic macro environment.
0 · Reply
TPTradingCo
TPTradingCo Aug. 26 at 8:26 PM
$A read what this company does. Don’t understand at least half of it. Started a position.
0 · Reply